Employees 498 Debt/Eq - Sales Y/Y TTM 145.34% Profit Margin -3191.11% Recom 1.32 Target Price 78.30 Option/Short Yes / Yes LT Debt/Eq - EPS Q/Q 8.05% Payout - Rel Volume 0.55 Prev Close 39.15 Sales Surprise 869.08% EPS Surprise -5.62% Sales Q/Q 912.38% Earnings Feb 27 AMC Avg ...
CYTK Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced -47.59% Cytokinetics, Incorporated price and volume Combination chart with 2 data series. Chart represents Cytokinetics, Incorporated price and volume over 1Y period The chart has 2 X axes displaying Time, and Time. The chart ha...
Molina Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $410.00, representing a 19.9% upside. In a report issued on April 15, Truist Financial also maintained a Buy rating on the stock with a $440.00 price target. Cytokinetics...
Low Target Price 60.00 Standard Deviation: 16.55 Number of Estimates 20 Date of Most Recent Estimate 03/06/25 Created with Highcharts 5.0.7# Estimates: 205060708090100110120130 Mean 79.30 High 120.00 Low 60.00 Created with Highcharts 5.0.7Price Estimate# EstimatesHighMeanLow# Estimates3 Week2 Week...
Goldman Sachs analyst revisits Rivian stock price target after Q4 earnings Rivian's R2 SUV, which is expected to challenge Tesla's Model Y, will launch early next year. RIVN Latest Commodity Market News Feb 20, 2025 4:37 PM EST
CYTK Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced -37.94% Cytokinetics, Incorporated price and volume Combination chart with 2 data series. Chart represents Cytokinetics, Incorporated price and volume over 1Y period The chart has 2 X axes di...
CYTK Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced -34.04% Cytokinetics, Incorporated price and volume Combination chart with 2 data series. Chart represents Cytokinetics, Incorporated price and volume over 1Y period The chart has 2 X axes displaying Time, and Time. The chart ...